4SCAR-CD44v6 T Cell Therapy Targeting Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Cancers Which Are CD44v6 Positive
Interventions: BIOLOGICAL: CD44v6-specific CAR gene-engineered T cells
Sponsor: Shenzhen Geno-Immune Medical Institute
Collaborators: Shenzhen Hospital of Southern Medical University|The Seventh Affiliated Hospital of Sun Yat-sen University|Shenzhen Children's Hospital